Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Vanqua Bio (United States)
Homepage:
vanquabio.com
Alternate names:
Vanqua Bio,
Vanqua Bio Inc.
ROR:
00qzw8x41
OpenAlex ID:
I4405266999
Works
10
Awards
1
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity
2021
·
Daniel Ysselstein
, Tiffany J. Young
, et al.
·
Movement Disorders
·
43
PDF
Patients’ experience with and perspectives on long-term use of continuous subcutaneous infusion of foslevodopa/foscarbidopa in Parkinson’s disease
2025
·
Michael Soileau
, Rajeev Kumar
, et al.
·
Journal of Neurology
·
7
PDF
Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
2023
·
Gregory Lane
, Guangyu Zhou
, et al.
·
medRxiv
·
4
PDF
c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities
2022
·
Kalpana Merchant
, James Sullivan
·
Movement Disorders
·
4
The Small Molecule VQ-101 Demonstrates Sustained Lysosomal Glucocerebrosidase (GCase) Activation in Idiopathic Parkinson’s Disease (S26.005)
2026
·
Maurizio Facheris
, Omer Siddiqui
, et al.
·
Neurology
An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020–2025)
2026
·
Sida Shen
·
Expert Opinion on Therapeutic Patents
Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
2024
·
Gregory Lane
, Guangyu Zhou
, et al.
PDF
Author Response: Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
2024
·
Gregory Lane
, Guangyu Zhou
, et al.
PDF
Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection
2024
·
Gregory Lane
, Guangyu Zhou
, et al.
Show more works
View as search
Works count:
10
Citation count:
101
Year
Topic
Type
